Nanologica AB (publ) (STO:NICA)
Sweden
· Delayed Price · Currency is SEK 1.165
+0.040 (3.56%)
Jun 19, 2025, 5:29 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| Chromatography | 1.44M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Chromatography Growth | -7.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Development Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Corporate | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Development and Chromatography | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Drug Development and Chromatography Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
| China | 654.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -6.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 601.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | 230.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 188.00K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Turkey | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sweden Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|